Ignite Creation Date:
2024-05-06 @ 2:59 AM
Last Modification Date:
2024-10-26 @ 11:26 AM
Study NCT ID:
NCT02174432
Status:
COMPLETED
Last Update Posted:
2020-10-23
First Post:
2014-06-24
Brief Title:
Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis
Sponsor:
Trevi Therapeutics
Organization:
Trevi Therapeutics
Organization Data
Organization:
Trevi Therapeutics
Class:
INDUSTRY
Study ID:
TR03ext
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Trevi Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None